These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 34922160)

  • 1. Sustained inflammation, coagulation activation and elevated endothelin-1 levels without macrovascular dysfunction at 3 months after COVID-19.
    Willems LH; Nagy M; Ten Cate H; Spronk HMH; Groh LA; Leentjens J; Janssen NAF; Netea MG; Thijssen DHJ; Hannink G; van Petersen AS; Warlé MC
    Thromb Res; 2022 Jan; 209():106-114. PubMed ID: 34922160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vascular Function, Systemic Inflammation, and Coagulation Activation 18 Months after COVID-19 Infection: An Observational Cohort Study.
    Willems LH; Jacobs LMC; Groh LA; Ten Cate H; Spronk HMH; Wilson-Storey B; Hannink G; van Kuijk SMJ; Ghossein-Doha C; Nagy M; Thijssen DHJ; van Petersen AS; Warlé MC
    J Clin Med; 2023 Feb; 12(4):. PubMed ID: 36835948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The vascular endothelium: the cornerstone of organ dysfunction in severe SARS-CoV-2 infection.
    Pons S; Fodil S; Azoulay E; Zafrani L
    Crit Care; 2020 Jun; 24(1):353. PubMed ID: 32546188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endothelial dysfunction contributes to COVID-19-associated vascular inflammation and coagulopathy.
    Zhang J; Tecson KM; McCullough PA
    Rev Cardiovasc Med; 2020 Sep; 21(3):315-319. PubMed ID: 33070537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL-1 induces throboxane-A2 (TxA2) in COVID-19 causing inflammation and micro-thrombi: inhibitory effect of the IL-1 receptor antagonist (IL-1Ra).
    Conti P; Caraffa A; Gallenga CE; Ross R; Kritas SK; Frydas I; Younes A; Di Emidio P; Ronconi G; Toniato E
    J Biol Regul Homeost Agents; 2020 Sep-Oct,; 34(5):1623-1627. PubMed ID: 32744052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impaired coagulation, liver dysfunction and COVID-19: Discovering an intriguing relationship.
    D'Ardes D; Boccatonda A; Cocco G; Fabiani S; Rossi I; Bucci M; Guagnano MT; Schiavone C; Cipollone F
    World J Gastroenterol; 2022 Mar; 28(11):1102-1112. PubMed ID: 35431501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular and molecular mechanisms in COVID-19 coagulopathy: role of inflammation and endotheliopathy.
    Cacciola R; Gentilini Cacciola E; Vecchio V; Cacciola E
    J Thromb Thrombolysis; 2022 Feb; 53(2):282-290. PubMed ID: 34687400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Cross-Talk between Thrombosis and Inflammatory Storm in Acute and Long-COVID-19: Therapeutic Targets and Clinical Cases.
    Acanfora D; Acanfora C; Ciccone MM; Scicchitano P; Bortone AS; Uguccioni M; Casucci G
    Viruses; 2021 Sep; 13(10):. PubMed ID: 34696334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-6 trans-signaling induces plasminogen activator inhibitor-1 from vascular endothelial cells in cytokine release syndrome.
    Kang S; Tanaka T; Inoue H; Ono C; Hashimoto S; Kioi Y; Matsumoto H; Matsuura H; Matsubara T; Shimizu K; Ogura H; Matsuura Y; Kishimoto T
    Proc Natl Acad Sci U S A; 2020 Sep; 117(36):22351-22356. PubMed ID: 32826331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Repressed Ang 1-7 in COVID-19 Is Inversely Associated with Inflammation and Coagulation.
    Carpenter RM; Young MK; Petri WAO; Lyons GR; Gilchrist C; Carey RM; Petri WA
    mSphere; 2022 Aug; 7(4):e0022022. PubMed ID: 35913134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Idiopathic venous thrombosis is related to systemic inflammatory response and to increased levels of circulating markers of endothelial dysfunction.
    Jezovnik MK; Poredos P
    Int Angiol; 2010 Jun; 29(3):226-31. PubMed ID: 20502419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ChAdOx1 vaccination, blood coagulation, and inflammation: No effect on coagulation but increased interleukin-6.
    Willems LH; Nagy M; Ten Cate H; Spronk HMH; Jacobs LMC; Kranendonk J; van Leeuwen M; Meijer D; Middeldorp S; Groh LA; Warlé MC
    Res Pract Thromb Haemost; 2021 Dec; 5(8):e12630. PubMed ID: 34934894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inflammation and Platelet Activation After COVID-19 Vaccines - Possible Mechanisms Behind Vaccine-Induced Immune Thrombocytopenia and Thrombosis.
    Ostrowski SR; Søgaard OS; Tolstrup M; Stærke NB; Lundgren J; Østergaard L; Hvas AM
    Front Immunol; 2021; 12():779453. PubMed ID: 34887867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The coagulopathy, endotheliopathy, and vasculitis of COVID-19.
    Iba T; Connors JM; Levy JH
    Inflamm Res; 2020 Dec; 69(12):1181-1189. PubMed ID: 32918567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of COVID-19 coagulopathy; laboratory characterization using thrombin generation and nonconventional haemostasis assays.
    White D; MacDonald S; Edwards T; Bridgeman C; Hayman M; Sharp M; Cox-Morton S; Duff E; Mahajan S; Moore C; Kirk M; Williams R; Besser M; Thomas W
    Int J Lab Hematol; 2021 Feb; 43(1):123-130. PubMed ID: 32892505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypercoagulability, endotheliopathy, and inflammation approximating 1 year after recovery: Assessing the long-term outcomes in COVID-19 patients.
    Fan BE; Wong SW; Sum CLL; Lim GH; Leung BP; Tan CW; Ramanathan K; Dalan R; Cheung C; Lim XR; Sadasiv MS; Lye DC; Young BE; Yap ES; Chia YW;
    Am J Hematol; 2022 Jul; 97(7):915-923. PubMed ID: 35477923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mast cells activated by SARS-CoV-2 release histamine which increases IL-1 levels causing cytokine storm and inflammatory reaction in COVID-19.
    Conti P; Caraffa A; Tetè G; Gallenga CE; Ross R; Kritas SK; Frydas I; Younes A; Di Emidio P; Ronconi G
    J Biol Regul Homeost Agents; 2020 Sep-Oct,; 34(5):1629-1632. PubMed ID: 32945158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphatidylserine inside out: a possible underlying mechanism in the inflammation and coagulation abnormalities of COVID-19.
    Argañaraz GA; Palmeira JDF; Argañaraz ER
    Cell Commun Signal; 2020 Dec; 18(1):190. PubMed ID: 33357215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. COVID-19 is a systemic vascular hemopathy: insight for mechanistic and clinical aspects.
    Smadja DM; Mentzer SJ; Fontenay M; Laffan MA; Ackermann M; Helms J; Jonigk D; Chocron R; Pier GB; Gendron N; Pons S; Diehl JL; Margadant C; Guerin C; Huijbers EJM; Philippe A; Chapuis N; Nowak-Sliwinska P; Karagiannidis C; Sanchez O; Kümpers P; Skurnik D; Randi AM; Griffioen AW
    Angiogenesis; 2021 Nov; 24(4):755-788. PubMed ID: 34184164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coronavirus-19 (SARS-CoV-2) induces acute severe lung inflammation via IL-1 causing cytokine storm in COVID-19: a promising inhibitory strategy.
    Conti P; Caraffa A; Gallenga CE; Ross R; Kritas SK; Frydas I; Younes A; Ronconi G
    J Biol Regul Homeost Agents; 2020; 34(6):1971-1975. PubMed ID: 33016027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.